Literature DB >> 20079600

Promotion of beta-cell differentiation by the alkaloid conophylline in porcine pancreatic endocrine cells.

M Kawakami1, A Hirayama, K Tsuchiya, H Ohgawara, M Nakamura, K Umezawa.   

Abstract

We previously found that conophylline, an alkaloid isolated from the leaves of Ervatamia microphylla, induced beta-cell differentiation in rat pancreatic acinar carcinoma cells and in cultured fetal rat pancreatic tissue and that it also decreased the blood glucose level in streptozotocin-treated fetal rats. In the present research, we looked into the effect of conophylline on the differentiation of newborn pig pancreatic endocrine cells into insulin-secreting cells. Conophylline potentiated the differentiation of monolayer cells into insulin-producing cells in the presence of nicotinamide in 3 weeks. Next we prepared islet-like cell clusters (ICC). Cononophylline together with nicotinamide also increased the number of insulin-producing cells and the insulin content in ICC in 3-6 weeks. The ICC thus prepared were sensitive to the glucose concentration for the insulin secretion. Conophylline increased the mRNA expression of PDX-1, neurogenin3, neuroD/Beta2, and insulin in ICC. Thus, the vinca alkaloid conophylline potentiated beta-cell differentiation in porcine pancreatic endocrine-rich cells in cluster cultures. Pig pancreatic cells are practical candidate for use in transplantation therapy. Conophylline may thus be useful for the large-scale preparation of porcine insulin-producing cells for the regeneration therapy of type-1 diabetes mellitus. Copyright (c) 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079600     DOI: 10.1016/j.biopha.2009.09.025

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  A small molecule differentiation inducer increases insulin production by pancreatic β cells.

Authors:  Elhadji M Dioum; Jihan K Osborne; Sean Goetsch; Jamie Russell; Jay W Schneider; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models.

Authors:  Kazuo Umezawa; Itaru Kojima; Siro Simizu; Yinzhi Lin; Hitomi Fukatsu; Naoki Koide; Yukiomi Nakade; Masashi Yoneda
Journal:  Hum Cell       Date:  2017-12-16       Impact factor: 4.174

Review 3.  Therapeutic phytogenic compounds for obesity and diabetes.

Authors:  Hee Soong Jung; Yun Lim; Eun-Kyoung Kim
Journal:  Int J Mol Sci       Date:  2014-11-21       Impact factor: 5.923

4.  Botanical Interventions to Improve Glucose Control and Options for Diabetes Therapy.

Authors:  Peter Smoak; Susan J Burke; J Jason Collier
Journal:  SN Compr Clin Med       Date:  2021-08-15

Review 5.  The Multifunctional Role of Herbal Products in the Management of Diabetes and Obesity: A Comprehensive Review.

Authors:  Md Mominur Rahman; Md Rezaul Islam; Sheikh Shohag; Md Emon Hossain; Md Saidur Rahaman; Fahadul Islam; Muniruddin Ahmed; Saikat Mitra; Mayeen Uddin Khandaker; Abubakr M Idris; Kumarappan Chidambaram; Talha Bin Emran; Simona Cavalu
Journal:  Molecules       Date:  2022-03-06       Impact factor: 4.411

6.  Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds.

Authors:  Cicero L T Chang; Yenshou Lin; Arlene P Bartolome; Yi-Ching Chen; Shao-Chih Chiu; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

Review 7.  Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes.

Authors:  Yoon Sin Oh
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-26       Impact factor: 2.629

8.  Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.

Authors:  Tomohiko Ohashi; Yukiomi Nakade; Mayu Ibusuki; Rena Kitano; Taeko Yamauchi; Satoshi Kimoto; Tadahisa Inoue; Yuji Kobayashi; Yoshio Sumida; Kiyoaki Ito; Haruhisa Nakao; Kazuo Umezawa; Masashi Yoneda
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.